SAT-034 The Effect of Natesto on Spermatogenesis, Reproductive Hormones, and Hypogonadal Symptoms. A Phase IV Study

INTRODUCTION AND OBJECTIVE: Exogenous testosterone (T) therapy is typically long-acting and causes azoospermia in up to 65% of the men. Natesto, dosed three times a day, is a short-acting, FDA approved nasal testosterone available since 2015. We hypothesized that Natesto can preserve spermatogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Masterson, Thomas A, Best, Jordan, Bitran, Josh, Molina, Manuel L, Ibrahim, Emad, Kaiser, Ursula B, Ramasamy, Ranjith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209674/
http://dx.doi.org/10.1210/jendso/bvaa046.646

Ejemplares similares

Ejemplares similares